Patent US2031594A successfully refreshed from Google Patents.
US5124332A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Substituted indoles as central nervous system agents
Assignee: Warner Lambert Co LLC
•
Filing: 1991-01-28
•
Granted: 1992-06-23
•
Expires: 2011-01-28
Abstract
Abstract Substituted indoles and derivatives thereof are described, as well as methods for the preparation and pharmaceutical composition of the same, which are useful as central nervous system agents and are particularly useful as dopaminergic, antipsychotic, and antihypertensive agents as well as for treating hyperprolactinaemia-related conditions and central nervous system disorders.
Inventors
- 👤 Lawrence D. Wise
- 👤 David J. Wurtrow
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-11-03 12:30
CPC Classifications
C; C07; C07D; C07D401/00; C07D401/02; C07D401/08; C07D401/14; C07D409/00; C07D409/14
Claims Analysis
Total Claims: 8
Claim 1
Independent Claim
407 words
A compound of Formula I: ##STR46## wherein R is ##STR47## wherein R 4 is aryl, unsubstituted or substituted by one to four substituents selected from lower alkyl, lower alkoxy, lower thioalkoxy, hydroxy, lower acyloxy, amino, ##STR48## wherein R 5 is lower alkyl, halogen, or trifluoromethyl, 2-k 3-, or 4-pyridinyl, unsubstituted or substituted by halogen, lower alkyl, hydroxy, lower acyloxy, lower alkoxy, amino, or ##STR49## wherein R 5 is as defined above, 2-, 4-, or 5-pyrimidinyl, unsubstituted or substituted by halogen, lower alkyl, hydroxy, lower acyloxy, lower alkoxy, amino, or ##STR50## wherein R 5 is as defined above, 2-pyrazinyl, unsubstituted or substituted by halogen, lower alkyl, hydroxy, lower acyloxy, lower alkoxy, amino, or ##STR51## wherein R 5 is as defined above, 2- or 3-furanyl, unsubstituted or substituted by halogen, lower alkyl, hydroxy, lower acyloxy, lower alkoxy, amino, or ##STR52## wherein R 5 is as defined above, 2-, or 3-thienyl, unsubstituted or substituted by halogen, lower alkyl, hydroxy, lower acyloxy, lower alkoxy, amino, or ##STR53## wherein R 5 is as defined above, 2-, 4-, or 5-imidazolyl, unsubstituted or substituted by halogen, lower alkyl, hydroxy, lower acyloxy, lower alkoxy, amino, or ##STR54## wherein R 5 is as defined above, 2-, 4-, or 5-thiazolyl, unsubstituted or substituted by halogen, lower alkyl, hydroxy, lower acyloxy, lower alkoxy, amino, or ##STR55## wherein R 5 is as defined above, or 2-, 3-, 4-, 5-, 6-, or 7-indolyl, unsubstituted or substituted by halogen, lower alkyl, hydroxy, lower acyloxy, lower alkoxy, amino, or ##STR56## wherein R 5 is as defined above; R 1 is hydrogen, --CN, or --CO 2 H; R 2 is hydrogen, lower alkyl, or cycloalkyl; R 3 is hydrogen, halogen, hydroxyl, lower alkoxy, lower alkyl, ##STR57## wherein R 6 is hydrogen or lower alkyl, ##STR58## wherein R 7 is hydrogen, lower alkyl, cycloalkyl, or aryl, unsubstituted or substituted by one to four substituents selected from lower alkyl, lower alkoxy, lower thioalkoxy, hydroxy, lower acyloxy, amino, ##STR59## wherein R 5 is as defined above, halogen, or trifluoromethyl, ##STR60## wherein R 8 is lower alkyl, cycloalkyl or aryl, unsubstituted or substituted by one to four substituents selected from lower alkyl, lower alkoxy, lower thioalkoxy, hydroxy, lower acyloxy, amino, ##STR61## wherein R 5 is as defined above, halogen, or trifluoromethyl, or --NH 2 ; n is zero or an integer of 1, 2, or 3; is a single or double bond; and corresponding geometric isomers thereof; or a pharmaceutically acceptable acid or base addition salt thereof.
Claim 2
Dependent Claim
407 words
A compound of Formula I: ##STR46## wherein R is ##STR47## wherein R 4 is aryl, unsubstituted or substituted by one to four substituents selected from lower alkyl, lower alkoxy, lower thioalkoxy, hydroxy, lower acyloxy, amino, ##STR48## wherein R 5 is lower alkyl, halogen, or trifluoromethyl, 2-k 3-, or 4-pyridinyl, unsubstituted or substituted by halogen, lower alkyl, hydroxy, lower acyloxy, lower alkoxy, amino, or ##STR49## wherein R 5 is as defined above, 2-, 4-, or 5-pyrimidinyl, unsubstituted or substituted by halogen, lower alkyl, hydroxy, lower acyloxy, lower alkoxy, amino, or ##STR50## wherein R 5 is as defined above, 2-pyrazinyl, unsubstituted or substituted by halogen, lower alkyl, hydroxy, lower acyloxy, lower alkoxy, amino, or ##STR51## wherein R 5 is as defined above, 2- or 3-furanyl, unsubstituted or substituted by halogen, lower alkyl, hydroxy, lower acyloxy, lower alkoxy, amino, or ##STR52## wherein R 5 is as defined above, 2-, or 3-thienyl, unsubstituted or substituted by halogen, lower alkyl, hydroxy, lower acyloxy, lower alkoxy, amino, or ##STR53## wherein R 5 is as defined above, 2-, 4-, or 5-imidazolyl, unsubstituted or substituted by halogen, lower alkyl, hydroxy, lower acyloxy, lower alkoxy, amino, or ##STR54## wherein R 5 is as defined above, 2-, 4-, or 5-thiazolyl, unsubstituted or substituted by halogen, lower alkyl, hydroxy, lower acyloxy, lower alkoxy, amino, or ##STR55## wherein R 5 is as defined above, or 2-, 3-, 4-, 5-, 6-, or 7-indolyl, unsubstituted or substituted by halogen, lower alkyl, hydroxy, lower acyloxy, lower alkoxy, amino, or ##STR56## wherein R 5 is as defined above; R 1 is hydrogen, --CN, or --CO 2 H; R 2 is hydrogen, lower alkyl, or cycloalkyl; R 3 is hydrogen, halogen, hydroxyl, lower alkoxy, lower alkyl, ##STR57## wherein R 6 is hydrogen or lower alkyl, ##STR58## wherein R 7 is hydrogen, lower alkyl, cycloalkyl, or aryl, unsubstituted or substituted by one to four substituents selected from lower alkyl, lower alkoxy, lower thioalkoxy, hydroxy, lower acyloxy, amino, ##STR59## wherein R 5 is as defined above, halogen, or trifluoromethyl, ##STR60## wherein R 8 is lower alkyl, cycloalkyl or aryl, unsubstituted or substituted by one to four substituents selected from lower alkyl, lower alkoxy, lower thioalkoxy, hydroxy, lower acyloxy, amino, ##STR61## wherein R 5 is as defined above, halogen, or trifluoromethyl, or --NH 2 ; n is zero or an integer of 1, 2, or 3; is a single or double bond; and corresponding geometric isomers thereof; or a pharmaceutically acceptable acid or base addition salt thereof.
Claim 3
Dependent Claim
68 words
A compound according to claim 1, in which R 4 is aryl, unsubstituted or substituted by one to four substituents selected from lower alkyl, lower alkoxy, lower thioalkoxy, hydroxy, lower acyloxy, amino, ##STR62## wherein R 5 is lower alkyl, halogen, or trifluoromethyl, 2-, 3-, or 4-pyridinyl, 2-, 4-, or 5-pyrimidinyl, 2-, or 3-furanyl, 2-, or 3-thienyl, 2-, 4-, or 5-thiazolyl, or 2-, 3-, 4-, 5-, 6-, or 7-indolyl,.
Claim 4
Dependent Claim
38 words
A compound according to claim 2, in which R 4 is aryl, 2-, 3-, or 4-pyridinyl, 2-, 4-, or 5-pyrimidinyl, 2-, or 3-furanyl, 2-, or 3-thienyl, 2-, 4-, or 5-thiazolyl, or 2-, 3-, 4-, 5-, 6-, or 7-indolyl.
Claim 5
Dependent Claim
56 words
A compound according to claim 1 selected from the group consisting of: Trans 3-[4-[2-[4-(2-pyridinyl)-1-piperazinyl]ethyl]cyclohexyl]-1H-indole; Cis 3-[4-[2-[4-(2-pyridinyl)-1-piperazinyl]ethyl]cyclohexyl]-1H-indole; Trans 3-[4-[2-[4-(2-pyrimidinyl)-1-piperazinyl]ethyl]cyclohexyl]-1H-indole, hydrochloride; Cis 3-[4-[2-(2-pyrimidinyl)-1-piperazinyl]ethyl]cyclohexyl]-1H-indole, hydrochloride; Trans 3-[4-[2-(3,6-dihydro-4-phenyl-1(2H)-pyridinyl)ethyl]cyclohexyl]-1H-indole; Cis 3-[4-[2-(3,6-dihydro-4-phenyl-1(2H)-pyridinyl)ethyl]cyclohexyl]-1H-indole; Trans 3-[4-[2-(3,6-dihydro-4-(2-thienyl)-1(2H)-pyridinyl)ethyl]cyclohexyl]-1H-indole; Cis 3-[4-[2-(3,6-dihydro-4-(2-thienyl)-1(2H)-pyridinyl)ethyl]cyclohexyl]-1H-indole. Trans 3-[4-[2-(3,6-dihydro-4-(2-pyridinyl)-1(2H)-pyridinyl)ethyl]cyclohexyl]-1H-indole. Cis 3-[4-[2-(3,6-dihydro-4-(2-pyridinyl)-1(2H)-pyridinyl)ethyl]cyclohexyl]-1H-indole; Trans 5-methoxy-3-[4-[2-[4-(2-pyridinyl)-1-piperazinyl]ethyl]cyclohexyl]-1H-indole. Cis 5-methoxy-3-[4-[2-[4-(2-pyridinyl)-1-piperazinyl]ethyl]cyclohexyl]-1H-indole; Trans 5-fluoro-3-[4-[2-[4-(2-pyridinyl)-1-piperazinyl]ethyl]cyclohexyl]-1H-indole; Cis 5-fluoro-3-[4-[2-[4-(2-pyridinyl)-1-piperazinyl]ethyl]cyclohexyl]-1H-indole; Trans 3-[4-[4-(2-pyridinyl)-1-piperazinylmethyl]cyclohexyl]-1H-indole; Cis 3-[4-[4-(2-pyridinyl)-1-piperazinylmethyl]cyclohexyl]-1H-indole. 3-[4-[2-[4-[(2-Pyridinyl)-1-piperazinyl]ethyl]cyclohexen-1-yl]-1H-indole; Trans 3-[4-[2-[4-(2-pyridinyl)-1-piperazinyl]ethyl]cyclohexyl]-1H-indol-5-ol; Cis 3-[4-[2-[4-(2-pyridinyl)-1-piperazinyl]ethyl]cyclohexyl]-1H-indol-5-ol; Trans 1-methyl-3-[4-[2-[4-(2-pyridinyl)-1-piperazinyl]ethyl]cyclohexyl]-1H-indole; and Cis 1-methyl-3-[4-[2-[4-(2-pyridinyl)-1-piperazinyl]ethyl]cyclohexyl]-1H-indole.
Claim 6
Dependent Claim
27 words
A method of treating schizophrenia comprising administering to a host suffering therefrom a therapeutic effective amount of a compound according to claim 1 in unit dosage form.
Claim 7
Dependent Claim
27 words
A method of treating depression comprising administering to a host suffering therefrom a therapeutic effective amount of a compound according to claim 1 in unit dosage form.
Claim 8
Dependent Claim
35 words
A pharmaceutical composition adapted for administration as a dopaminergic, antipsychotic, or antidepressant agent comprising a therapeutic effective amount of a compound according to claim 1 in admixture with a pharmaceutically acceptable excipient, diluent, or carrier.
References Cited (Backward Citations)
EP0345808A1
Cited
US4954502A
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1995-06-23 | 1995-12-23 | 1996-06-23 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1999-06-23 | 1999-12-23 | 2000-06-23 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 2003-06-23 | 2003-12-23 | 2004-06-23 | $7700.00 | Window Closed / Lapsed |